---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-278068"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2026-06-23T00:22:28+00:00"
generated_at: "2026-06-23T10:05:34.794903+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics shareholders approve stock issuance for warrant exercises

## Summary
- Proposal 1 passed: 9,090,763 votes for issuance of up to 925,927 shares from Series A and B warrants (March 2026 private placement).
- Proposal 2 passed: 9,091,165 votes for issuance of up to 2,344,828 shares from Common Warrants (November 2025 inducement).
- Both proposals had ~9.09M for, ~398k against, ~18k abstentions at the June 18, 2026 special meeting.

## SEC filing metadata
- accession: 0001193125-26-278068
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2026-06-23T00:22:28+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312526278068/0001193125-26-278068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312526278068/d158247d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-278068
- JSON: https://secwatch.observer/filing/0001193125-26-278068.json
- Plain text: https://secwatch.observer/filing/0001193125-26-278068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.